Viral Sensitizers Potentiate the Infection of Cancer Cells Via NF-kB
Genetically engineered oncolytic viruses (OVs) have been proven to be effective anti-cancer agents. However, the heterogeneity of tumours and obligate attenuation of OVs to achieve safety can limit their efficacy. Our lab has previously shown that diverse small molecules, which we have termed “Viral...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en |
| Published: |
Université d'Ottawa / University of Ottawa
2020
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10393/40524 http://dx.doi.org/10.20381/ruor-24757 |